title: Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study.
abstract: The sensitization hypothesis posits a neuroadaptation model in which exposure to stimulants results in dopamine system alterations that, in turn, increase sensitivity to the reinforcing effects of the previously experienced drug. This study examines whether stimulant treatment in childhood confers increased risk for substance use and abuse in later life, as the model predicts. Children, ages 7-12 years, with developmental reading disorders but no other psychiatric diagnoses were randomly assigned to methylphenidate treatment (n = 43) or matching placebo (n = 66) for 12-18 weeks. At 16-year follow-up (mean age 26 years), 94% of probands and 129 normal comparisons were evaluated by trained clinicians who were blind to group and treatment status. There were no significant differences between groups on the prevalence of substance use disorder (abuse or dependence) for any of the seven drug categories studied. There were no significant group differences among substance abusers regarding age at onset, duration, or number of episodes of substance abuse and dependence. Significantly more normals (60%) than treated (46%) and untreated probands (41%) ever used stimulants in adolescence or adulthood. Findings from this randomized trial contradict the notion that stimulant treatment in childhood leads to substance use or abuse in later life. The sensitization hypothesis is not supported.
authors.affiliation: New York University Child Study Center, New York University School of Medicine, New York, New York 10016, USA. sa.mannuzza@med.nyu.edu
authors.forename: Salvatore
authors.initials: S
authors.lastname: Mannuzza
authors.forename: Rachel G
authors.initials: RG
authors.lastname: Klein
authors.forename: John L
authors.initials: JL
authors.lastname: Moulton
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008393:Marriage; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D011446:Prospective Studies; D018570:Risk Assessment; D012959:Socioeconomic Factors; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000209:etiology*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate